FNDC5 and sarcopenia: Daniel de Luis et al. have indicated that Irisin levels were significantly lower in patients with sarcopenia than in non-sarcopenic individuals; furthermore, higher Irisin levels were associated with a 61 % reduction in the risk of sarcopenia, and Irisin levels showed a positive correlation with AMSI.